Prophylactic use of anti-CMV immunoglobulins in heart transplant recipients: a study on its safety

Transplant Proc. 1989 Feb;21(1 Pt 3):2504-5.

Authors

H J Metselaar¹, J Velzing, P H Rothbarth, A H Balk, B Mochtar, W Weimar

Affiliation

¹ Department of Internal Medicine, University Hospital Rotterdam, The Netherlands.

PMID: 2539677

No abstract available

MeSH terms

Antibodies, Viral / therapeutic use*
Cytomegalovirus / immunology*
Follow-Up Studies
HIV Antigens / analysis
HIV Seropositivity / etiology
Heart Transplantation*
Hepatitis B Surface Antigens / analysis
Humans
Immune Sera / adverse effects
Immunization, Passive* / adverse effects
Immunoglobulins*
Immunoglobulins, Intravenous
Liver / enzymology
Postoperative Complications / etiology
Postoperative Complications / prevention & control

Substances

Antibodies, Viral
HIV Antigens
Hepatitis B Surface Antigens
Immune Sera
Immunoglobulins
Immunoglobulins, Intravenous
cytomegalovirus-specific hyperimmune globulin